JS

Johannes Scheid

TU The Rockefeller University: 13 patents #21 of 698Top 4%
Caltech: 12 patents #169 of 4,321Top 4%
📍 New York, NY: #1,451 of 20,192 inventorsTop 8%
🗺 New York: #11,369 of 115,490 inventorsTop 10%
Overall (All Time): #366,437 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
12428472 Human immunodeficiency virus neutralizing antibodies and methods of use thereof Michel Nussenzweig, Pamela J. Bjorkman, Ron Diskin 2025-09-30
12071470 Human immunodeficiency virus neutralizing antibodies and methods of use thereof Michel Nussenzweig, Pamela J. Bjorkman, Ron Diskin 2024-08-27
12054538 Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 Ron Diskin, Pamela J. Bjorkman, Michel Nussenzweig 2024-08-06
11634478 Human immunodeficiency virus neutralizing antibodies and methods of use thereof Michel Nussenzweig, Pamela J. Bjorkman, Ron Diskin 2023-04-25
11472868 Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 Ron Diskin, Pamela J. Bjorkman, Michel Nussenzweig 2022-10-18
11155605 Nucleic acids encoding broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 ENV subunits Michel Nussenzweig, Pamela J. Bjorkman, Louise Scharf 2021-10-26
10889633 Human immunodeficiency virus neutralizing antibodies and methods of use thereof Michel Nussenzweig, Pamela J. Bjorkman, Ron Diskin 2021-01-12
10590187 Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with gp120 Ron Diskin, Pamela J. Bjorkman, Michel Nussenzweig 2020-03-17
10421803 Broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 Env subunits Michel Nussenzweig, Pamela J. Bjorkman, Louise Scharf 2019-09-24
9890207 Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 Ron Diskin, Pamela J. Bjorkman, Michel Nussenzweig 2018-02-13
9783594 Human immunodeficiency virus neutralizing antibodies and methods of use thereof Michel Nussenzweig, Pamela J. Bjorkman, Ron Diskin 2017-10-10
9493549 Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth Ron Diskin, Pamela J. Bjorkman, Michel Nussenzweig 2016-11-15
8673307 HIV-1 anti-core neutralizing antibodies that target a conformational epitope within the ALPHA5-helix of GP120 Michel Nussenzweig, John Pietzsch 2014-03-18